Mesothelioma Treatment Market: By Drug Class, By Application, By Route of Administration, By Distribution Channel, and Geography  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Mesothelioma Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Class (Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, and Others), By Application (Pleural Mesothelioma and Peritoneal Mesothelioma), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region  

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Mesothelioma Treatment Market size was valued at US$ 297.58 million in 2023 and is poised to grow at a CAGR of 8.7% during the forecast period 2024 to 2030. Mesothelioma is a rare and aggressive form of cancer that occurs in the thin layer tissue that covers the majority of the internal organs. Mesothelioma most often affects the tissue that surrounds the lungs (pleura), which is called pleural mesothelioma. Other, rarer types of mesothelioma affect tissue in the abdomen (peritoneal mesothelioma), around the heart and around the testicles. Pleural mesothelioma is the most common type of mesothelioma. Mesothelioma primarily caused by the inhalation of asbestos fibers, can be diagnosed in older individuals who worked with asbestos products in an industrial setting as there is no cure currently exists, mesothelioma patients can usually improve their prognosis through some form of treatment available.

Chemotherapy is a crucial component of palliative care. AstraZeneca, for example, is active in the research and development of medicines for malignant mesothelioma. Durvalumab, tazemetostat, tremelimumab, nintedanib, ADI-PEG 20, and HSV 1716 are all major pipeline medicines. Because of the rising incidence rate, rising air pollution, rising senior population, and rising healthcare cost, the malignant mesothelioma treatment market is expected to see significant expansion in the near future. Moreover, throughout the projected period, the development of novel therapies and the introduction of advanced treatment options are expected to present attractive potential prospects for the malignant mesothelioma market. However, the mesothelioma treatment market is constrained by a long latent period between development and symptom, a lack of effective treatment, and a low surveillance rate.

summary download arrow Download Free Sample

Mesothelioma Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.7%

Largest Market

North America

Fastest Growing Market

Europe

Mesothelioma Treatment Market Dynamics

Out of all types of mesothelioma, malignant pleural mesothelioma segment is anticipated to grow at significant rate and accounts for 70% of all mesothelioma cases followed by malignant peritoneal mesothelioma which accounts 15-20% of all mesothelioma cases. Many companies are focusing on the collaborations in order to study the combinations of various drugs. The combination therapies are improving the survival rates which is encouraging the R&D activities. According to the Cancer Research UK, 1 in every 140 men and 1 in every 710 women are diagnosed with malignant mesothelioma. The increasing cases of malignant mesothelioma are adding fuel to the mesothelioma treatment market growth.

Mesothelioma Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 297.58 million

Market CAGR

8.7%

By Drug Class

  • Alkylating agents
  • Antimetabolites
  • Plant alkaloids
  • Antitumor Antibiotics
  • Others

By Application

  • Pleural Mesothelioma
  • Peritoneal Mesothelioma

By Route of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Key Features of the Report

  • The mesothelioma treatment market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global mesothelioma treatment market size was valued at US$ 297.58 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.

The Mesothelioma Treatment Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Europe is the fastest-growing for Mesothelioma Treatment Market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Mesothelioma Treatment Market Introduction 
2.1.Global Mesothelioma Treatment Market  - Taxonomy
2.2.Global Mesothelioma Treatment Market  - Definitions
2.2.1.Drug Class
2.2.2.Application
2.2.3.Route of Administration
2.2.4.Distribution Channel
2.2.5.Region
3.Global Mesothelioma Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Mesothelioma Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Mesothelioma Treatment Market By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Alkylating agents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Antimetabolites
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Plant alkaloids
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Antitumor Antibiotics
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Mesothelioma Treatment Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Pleural Mesothelioma
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Peritoneal Mesothelioma
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Mesothelioma Treatment Market By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Oral
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Parenteral
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Mesothelioma Treatment Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Mesothelioma Treatment Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Mesothelioma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Alkylating agents
10.1.2.Antimetabolites
10.1.3.Plant alkaloids
10.1.4.Antitumor Antibiotics
10.1.5.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Pleural Mesothelioma
10.2.2.Peritoneal Mesothelioma
10.3.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Oral
10.3.2.Parenteral
10.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies
10.4.2.Retail Pharmacies
10.4.3.Online Pharmacies
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Mesothelioma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Alkylating agents
11.1.2.Antimetabolites
11.1.3.Plant alkaloids
11.1.4.Antitumor Antibiotics
11.1.5.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Pleural Mesothelioma
11.2.2.Peritoneal Mesothelioma
11.3.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Oral
11.3.2.Parenteral
11.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies
11.4.2.Retail Pharmacies
11.4.3.Online Pharmacies
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Mesothelioma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Alkylating agents
12.1.2.Antimetabolites
12.1.3.Plant alkaloids
12.1.4.Antitumor Antibiotics
12.1.5.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Pleural Mesothelioma
12.2.2.Peritoneal Mesothelioma
12.3.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Oral
12.3.2.Parenteral
12.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies
12.4.2.Retail Pharmacies
12.4.3.Online Pharmacies
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Mesothelioma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Alkylating agents
13.1.2.Antimetabolites
13.1.3.Plant alkaloids
13.1.4.Antitumor Antibiotics
13.1.5.Others
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Pleural Mesothelioma
13.2.2.Peritoneal Mesothelioma
13.3.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Oral
13.3.2.Parenteral
13.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies
13.4.2.Retail Pharmacies
13.4.3.Online Pharmacies
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Mesothelioma Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Alkylating agents
14.1.2.Antimetabolites
14.1.3.Plant alkaloids
14.1.4.Antitumor Antibiotics
14.1.5.Others
14.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Pleural Mesothelioma
14.2.2.Peritoneal Mesothelioma
14.3.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Oral
14.3.2.Parenteral
14.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies
14.4.2.Retail Pharmacies
14.4.3.Online Pharmacies
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Teva Pharmaceuticals (Israel)
15.2.2.Boehringer Ingelheim GmbH (Germany)
15.2.3.Mylan N.V. (U.S)
15.2.4.Fresenius Kabi AG (Germany)
15.2.5.Sun Pharmaceuticals Industries Ltd. (India)
15.2.6.Concordia International Corp. (U.K)
15.2.7.Kyowa Hakko Kirin Co Ltd. (Japan)
15.2.8.MolMed SpA (Italy)
15.2.9.Ono Pharmaceutical Co. Ltd. (Japan)
15.2.10.Nichi-Iko Pharmaceutical Co. (Japan)
16. Research Methodology 
17. Appendix and Abbreviations 

 

Key Market Players

  • Teva Pharmaceuticals
  • Boehringer Ingelheim GmbH
  • Mylan N.V.
  • Fresenius Kabi AG
  • Sun Pharmaceuticals Industries Ltd.
  • Concordia International Corp.
  • Kyowa Hakko Kirin Co Ltd.
  • MolMed SpA
  • Ono Pharmaceutical Co. Ltd.
  • Nichi-Iko Pharmaceutical Co.

Related Industry Reports

Antibiotics Market

Animal Antibiotics And Antimicrobials Market

Multi Drug Resistant Antibiotics Market

Global Acne Treatment Market